Prednisone in Uric Acid Lowering in Symptomatic Heart Failure Patients with Hyperuricemia -- The PUSH-PATH3 Study.

Hong Meng,Gang Liu,Jianlong Zhai,Yuzhi Zhen,Qingzhen Zhao,Mingqi Zheng,Guoping Ma,Le Wang,Li Tian,Lishuang Ji,Linan Duan,Lizhuo Li,Kunshen Liu,Chao Liu
DOI: https://doi.org/10.3899/jrheum.141037
2015-01-01
The Journal of Rheumatology
Abstract:OBJECTIVE:To determine the safety and efficacy of prednisone in patients with symptomatic heart failure (HF) and hyperuricemia. METHODS:Prednisone therapy was administered for a short time to 191 symptomatic HF patients with hyperuricemia (serum uric acid > 7 mg/dl). RESULTS:Prednisone significantly reduced serum uric acid by 2.99 mg/dl (p < 0.01) and serum creatinine by 0.17 mg/dl (p < 0.01). These favorable effects were associated with a remarkable increase in urine output, improvement in renal function, and improvement in clinical status. CONCLUSION:Prednisone can be used safely in symptomatic HF patients with hyperuricemia.
What problem does this paper attempt to address?